Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion
- 600 Downloads
The results of platelet-rich plasma (PRP) in spinal fusion applications are limited and controversial. Both beneficial and inhibitory effects have been shown. In this prospective randomised controlled trial, our objective was to assess both the clinical and radiological effect of PRP when added to autograft iliac crest bone in posterior lumbar interbody fusion.
Methods and materials
Forty patients were recruited for the study fulfilling strict entry requirements and were randomised with a 1:1 ratio. In each group, one patient was lost to follow-up. Thirtyeight patients completed the Visual Analogue Scale (VAS), the Oswestry Disability Index (ODI), and the Short-Form 36 (SF-36) preoperatively and postoperatively at 3, 6, 12, and 24 months, respectively. CT-scans of the lumbar spine were taken at 3, 6, and 12 months. Posterior stabilisation was achieved with pedicle screws and interbody fusion was aimed at with carbon cages filled with autologous bone.
Baseline demographic data (age, sex, smoking history, preoperative outcome measures) showed no relevant difference between groups. For patients who received autograft only, the mean VAS improved by 4.0 points (p < 0.01), mean ODI improved by 32.1 points (p < 0.001), and mean SF-36 showed statistically significant improvement in each of the eight domains and in the physical (p < 0.001) and mental (p < 0.001) component summary measures. For patients who received autograft with PRP, the mean VAS improved by 4.92 points (p < 0.01), mean ODI improved by 30 points (p < 0.001), and mean SF-36 showed statistically significant improvement in six of the eight domains (p < 0.02) and in the physical (p = 0.016) and mental (p < 0.001) component summary measures. The improvement of the VAS score and the physical component summary score was more pronounced in patients who received autograft with PRP. These differences were, however, not statistically significant. CT-scans showed uneventful osseous healing in all but one patient with no difference between groups.
In this prospective randomised controlled clinical and radiological trial, adding PRP in posterior lumbar interbody fusion did not lead to a substantial improvement or deterioration when compared with autologous bone only. No inhibitory effect of PRP was observed on CT-scans. From a clinical and radiological point of view, the use of PRP seems to be justified in posterior lumbar interbody fusion surgery. From an economical point of view, the expense of using PRP cannot be justified until statistical significance can be reached in a larger study.
KeywordsLumbar spine Fusion Platelet-rich plasma Randomised controlled trial
Conflict of interest
The reviewers and the surgeon have and had no personal or financial interest in companies selling AGF- or PRP-technology, nor have they received any financial support from them.
- 1.Archundia TR, Soriano JC, Corona JN (2007) Utility of platelet-rich plasma and growth factors in bone defects. Act Orthop MexicanaGoogle Scholar
- 2.Arm DM, Lowery GL, Hood AG Characterization of an autologous platelet gel containing multiple growth factors. Presented at the 45th Orthopaedic Research Society meeting, AnaheimGoogle Scholar
- 6.Brantigan JW, Steffee AD, Lewis ML, Quinn LM, Persenaire JM (1996) Lumbar interbody fusion using the Brantigan I/F cage for PLIF and the VSP pedicle screw system: two-year results of a Food and Drug Administration IDE clinical trial. In: Hudson, LeHuec JC (eds) Intersomatique du Rachis Lumbaire, Montpellier, France, Sauramps MedicalGoogle Scholar
- 12.Cieslick-Bielecka A, Bielecki T, Gazdzik TS, Cieslik T, Szczepanski T (2008) Improved treatment of mandibular odontogenic cysts with platelet-rich gel. Oral Surg 105(4):423–429Google Scholar
- 13.Dori F, Nikolidakis D, Huszar T, Arweiler NB, Gera I, Sculean A (2008) Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral. J Clin Periodont 35(1):44–50Google Scholar
- 19.Hannon T, Polston G, Petarske W et al (1996) Determination of platelet yields from platelet rich plasma for five autotransfusion machines. Anaesth Analg 88:104–109Google Scholar
- 22.Kevy S, Jacobson M (2004) Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corp Technol 36:28–35Google Scholar
- 28.Mc Afee PC (1999) Current concepts review: interbody fusion cages in reconstructive operations of the spine. J Bone Joint Surg Am 81:859–880Google Scholar
- 29.Mehta S, Watson JT (2008) Platelet rich concentrate: basic science and current clinical applications. JOT 22(6):432–438Google Scholar
- 31.Obremskey WT, Marotta JS, Yaszemski MJ, Churchill LR, Boden SD, Dirschl DR. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics. J Bone Joint Surg Am 89:1641–1649Google Scholar
- 33.Ranly DM, McMillan J, Keller T, Lohmann CH, Meunch T, Cochran DL, Schwartz Z, Boyan BD (2005) Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am 287:2052–2064CrossRefGoogle Scholar
- 36.Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME (2007) User’s Manual fot the SF-36v2® Health Survey, 2nd edn. QualityMetric Incorporated, LincolnGoogle Scholar